Literature DB >> 11008977

Usefulness of procalcitonin for diagnosis of infection in cardiac surgical patients.

A Aouifi1, V Piriou, O Bastien, P Blanc, H Bouvier, R Evans, M Célard, F Vandenesch, R Rousson, J J Lehot.   

Abstract

OBJECTIVE: To determine the value of procalcitonin (PCT) as a marker of postoperative infection after cardiac surgery.
DESIGN: A prospective single institution three phase study.
SETTING: University cardiac surgical intensive care unit (31 beds). PATIENTS: Phase 1: To determine the normal perioperative kinetics of PCT, 20 consecutive patients undergoing elective cardiac surgery with cardiopulmonary bypass were included. Phase 2: To determine whether PCT may be useful for diagnosis of postoperative infection, 97 consecutive patients with suspected infection were included. Phase 3: To determine the ability of PCT to differentiate patients with septic shock from those with cardiogenic shock, 26 patients with postoperative circulatory failure were compared.
MEASUREMENTS AND MAIN RESULTS: Phase 1: Serum samples were drawn for PCT determination after induction of anesthesia (baseline), at the end of surgery, and daily until postoperative day (POD) 8. Baseline serum PCT concentration was 0.17 +/- 0.08 ng/mL (mean +/- SD). Serum PCT increased after cardiac surgery with a peak on POD 1 (1.08 +/- 1.36). Serum PCT returned to normal range on POD 3 and remained stable thereafter. Phase 2: In patients with suspected infection, serum PCT was measured at the same time of C-reactive protein (CRP) and bacteriologic samples. Among the 97 included patients, 54 were infected with pneumonia (n = 17), bacteremia (n = 16), mediastinitis (n = 9), or septic shock (n = 12). In the 43 remaining patients, infection was excluded by microbiological examinations. In noninfected patients, serum PCT concentration was 0.41 +/- 0.36 ng/mL (range, 0.08-1.67 ng/mL). Serum PCT concentration was markedly higher in patients with septic shock (96.98 +/- 119.61 ng/mL). Moderate increase in serum PCT concentration occurred during pneumonia (4.85 +/-3.31 ng/mL) and bacteremia (3.57 +/- 2.98 ng/mL). Serum PCT concentration remained low during mediastinitis (0.80 +/- 0.58 ng/mL). Five patients with mediastinitis, two patients with bacteremia, and one patient with pneumonia had serum PCT concentrations of <1 ng/mL. These eight patients were administered antibiotics previously and serum PCT was measured during a therapeutic antibiotic window. For prediction of infection by PCT, the best cutoff value was 1 ng/mL, with sensitivity 85%, specificity 95%, positive predictive value 96%, and negative predictive value 84%. Serum CRP was high in all patients without intergroup difference. For prediction of infection by CRP, a value of 50 mg/L was sensitive (84%) but poorly specific (40%). Comparing the area under the receiver operating characteristic curves, PCT was better than CRP for diagnosis of postoperative sepsis (0.82 for PCT vs. 0.68 for CRP). Phase 3: Serum PCT concentration was significantly higher in patients with septic shock than in those with cardiogenic shock (96.98 +/- 119.61 ng/mL vs. 11.30 +/- 12.3 ng/mL). For discrimination between septic and cardiogenic shock, the best cutoff value was 10 ng/mL, with sensitivity of 100% and specificity of 62%.
CONCLUSION: Cardiac surgery with cardiopulmonary bypass influences serum PCT concentration with a peak on POD 1. In the presence of fever, PCT is a reliable marker for diagnosis of infection after cardiac surgery, except in patients who previously received antibiotics. PCT was more relevant than CRP for diagnosis of postoperative infection. During a postoperative circulatory failure, a serum PCT concentration >10 ng/mL is highly indicative of a septic shock.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11008977     DOI: 10.1097/00003246-200009000-00008

Source DB:  PubMed          Journal:  Crit Care Med        ISSN: 0090-3493            Impact factor:   7.598


  24 in total

Review 1.  Persistent systemic inflammation in chronic critical illness.

Authors:  Christopher E Cox
Journal:  Respir Care       Date:  2012-06       Impact factor: 2.258

2.  Procalcitonin does discriminate between sepsis and systemic inflammatory response syndrome.

Authors:  R Arkader; E J Troster; M R Lopes; R R Júnior; J A Carcillo; C Leone; T S Okay
Journal:  Arch Dis Child       Date:  2005-12-02       Impact factor: 3.791

3.  Diagnostic study and meta-analysis of C-reactive protein as a predictor of postoperative inflammatory complications after gastroesophageal cancer surgery.

Authors:  Rene Warschkow; Ignazio Tarantino; Kristjan Ukegjini; Ulrich Beutner; Sascha A Müller; Bruno M Schmied; Thomas Steffen
Journal:  Langenbecks Arch Surg       Date:  2012-03-08       Impact factor: 3.445

4.  Evaluation of a research use only luminex based assay for measurement of procalcitonin in serum samples.

Authors:  Charles Garrigan; Jennifer Han; Pam Tolomeo; Katherine J Johnson; Stephen R Master; Ebbing Lautenbach; Irving Nachamkin
Journal:  Am J Transl Res       Date:  2016-10-15       Impact factor: 4.060

Review 5.  Procalcitonin: improved biochemical severity stratification and postoperative monitoring in severe abdominal inflammation and sepsis.

Authors:  B Rau; C M Krüger; M K Schilling
Journal:  Langenbecks Arch Surg       Date:  2004-03-06       Impact factor: 3.445

6.  Eosinopenia is a reliable marker of sepsis on admission to medical intensive care units.

Authors:  Khalid Abidi; Ibtissam Khoudri; Jihane Belayachi; Naoufel Madani; Aicha Zekraoui; Amine Ali Zeggwagh; Redouane Abouqal
Journal:  Crit Care       Date:  2008-04-24       Impact factor: 9.097

7.  Use of a Combination Biomarker Algorithm To Identify Medical Intensive Care Unit Patients with Suspected Sepsis at Very Low Likelihood of Bacterial Infection.

Authors:  Jennifer H Han; Irving Nachamkin; Susan E Coffin; Jeffrey S Gerber; Barry Fuchs; Charles Garrigan; Xiaoyan Han; Warren B Bilker; Jacqueleen Wise; Pam Tolomeo; Ebbing Lautenbach
Journal:  Antimicrob Agents Chemother       Date:  2015-08-03       Impact factor: 5.191

8.  Non-infectious causes of elevated procalcitonin and C-reactive protein serum levels in pediatric patients with hematologic and oncologic disorders.

Authors:  Hans Jürgen Dornbusch; Volker Strenger; Petra Sovinz; Herwig Lackner; Wolfgang Schwinger; Reinhold Kerbl; Christian Urban
Journal:  Support Care Cancer       Date:  2008-01-15       Impact factor: 3.603

9.  Usefulness of procalcitonin for diagnosing complicating sepsis in patients with cardiogenic shock.

Authors:  Alexander Geppert; Angela Steiner; Georg Delle-Karth; Gottfried Heinz; Kurt Huber
Journal:  Intensive Care Med       Date:  2003-06-20       Impact factor: 17.440

10.  Procalcitonin in patients with acute coronary syndromes and cardiogenic shock submitted to percutaneous coronary intervention.

Authors:  Claudio Picariello; Chiara Lazzeri; Marco Chiostri; Gianfranco Gensini; Serafina Valente
Journal:  Intern Emerg Med       Date:  2009-07-08       Impact factor: 3.397

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.